Find out more about Sibel Saya's experience
Sibel Saya's highlights
FEATURED Journal article
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary careRead more
Sibel Saya's selected work
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in..
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutati..
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with an..
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mu..
The use of a risk assessment and decision support tool (CRISP) compared with usual care in..
Displaying the 14 most recent scholarly works by Sibel Saya.
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care
Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery
Journal article | 2019 | British Journal of General Practice
BACKGROUND: In Australia, evidence-based guidelines recommend that women consider taking selective oestrogen receptor modulators (..
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth C Page, Elizabeth K Bancroft, Mark N Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh, D Gareth Evans, Jeanette Rothwell, Lovise Maehle, Eli Marie Grindedal, Paul James, Lyon Mascarenhas, Joanne McKinley, Lucy Side, Tessy Thomas, Christi van Asperen, et al.
Journal article | 2019 | European Urology
BACKGROUND: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluatin..
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
Elizabeth K Bancroft, Sibel Saya, Emma Brown, Sarah Thomas, Natalie Taylor, Jeanette Rothwell, Jennifer Pope, Anthony Chamberlain, Elizabeth Page, Sarah Benafif, Helen Hanson, Alexander Dias, Christos Mikropoulos, Louise Izatt, Lucy Side, Lisa Walker, Alan Donaldson, Jackie A Cook, Julian Barwell, Vicki Wiles, et al.
Journal article | 2019 | Journal of Medical Genetics
BACKGROUND: Germline TP53 gene pathogenic variants (pv) cause a very high lifetime risk of developing cancer, almost 100% for wome..
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.
Mark A Jenkins, Aung K Win, James G Dowty, Robert J MacInnis, Enes Makalic, Daniel F Schmidt, Gillian S Dite, Mirosl Kapuscinski, Mark Clendenning, Christophe Rosty, Ingrid M Winship, Jon D Emery, Sibel Saya, Finlay A Macrae, Dennis J Ahnen, David Duggan, Jane C Figueiredo, Noralane M Lindor, Robert W Haile, John D Potter, et al.
Journal article | 2019 | Familial Cancer
Before SNP-based risk can be incorporated in colorectal cancer (CRC) screening, the ability of these SNPs to estimate CRC risk for..
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
Elizabeth K Bancroft, Sibel Saya, Elizabeth C Page, Kathryn Myhill, Sarah Thomas, Jennifer Pope, Anthony Chamberlain, Rachel Hart, Wayne Glover, Jackie Cook, Derek J Rosario, Brian T Helfand, Christina Hutten Selkirk, Rosemarie Davidson, Mark Longmuir, Diana M Eccles, Neus Gadea, Carole Brewer, Julian Barwell, Monica Salinas, et al.
Journal article | 2019 | BJU International
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial
Jennifer G Walker, Finlay Macrae, Ingrid Winship, Jasmeen Oberoi, Sibel Saya, Shakira Milton, Adrian Bickerstaffe, James G Dowty, Richard De Abreu Lourenco, Malcolm Clark, Louise Galloway, George Fishman, Fiona M Walter, Louisa Flander, Patty Chondros, Driss Ait Ouakrim, Marie Pirotta, Lyndal Trevena, Mark A Jenkins, Jon D Emery
Journal article | 2018 | Trials
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
Christos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick, Tokhir Dadaev, Charles Brendler, Elizabeth Page, Alexander Dias, D Gareth Evans, Jeanette Rothwell, Lovise Maehle, Karol Axcrona, Kate Richardson, Diana Eccles, Thomas Jensen, Palle J Osther, Christi J van Asperen, Hans Vasen, Lambertus A Kiemeney, et al.
Journal article | 2018 | British Journal of Cancer
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya, Emma Killick, Sarah Thomas, Natalie Taylor, Elizabeth K Bancroft, Jeanette Rothwell, Sarah Benafif, Alexander Dias, Christos Mikropoulos, Jenny Pope, Anthony Chamberlain, Ranga Gunapala, Louise Izatt, Lucy Side, Lisa Walker, Susan Tomkins, Jackie Cook, Julian Barwell, Vicki Wiles, Lauren Limb, et al.
Journal article | 2017 | Familial Cancer
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
Elena Castro, Christos Mikropoulos, Elizabeth K Bancroft, Tokhir Dadaev, Chee Goh, Natalie Taylor, Edward Saunders, Nigel Borley, Diana Keating, Elizabeth C Page, Sibel Saya, Stephen Hazell, Naomi Livni, Nandita deSouza, David Neal, Freddie C Hamdy, Pardeep Kumar, Antonis C Antoniou, Zsofia Kote-Jarai, Rosalind A Eeles
Journal article | 2016 | The Oncologist
Prostate-specific antigen velocity as a predictive biomarker in a prospective prostate cancer screening study (IMPACT study)
Christos Mikropoulos, Christina Selkirk, Sibel Saya, Elizabeth Bancroft, Tokhir Dadaev, Charles Brendler, Edward Saunders, Daniel Leongamornlert, Elizabeth Page, Clara Cieza Borrella, Sue Moss, Zsofia Kote-Jarai, Brian Helfand, Ros A Eeles
Conference Proceedings | 2015 | Journal of Clinical Oncology
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew, Lovise Maehle, Karol Axcrona, D Gareth Evans, Barbara Bulman, Diana Eccles, Donna McBride, Christi van Asperen, Hans Vasen, Lambertus A Kiemeney, Janneke Ringelberg, et al.
Journal article | 2014 | European Urology
Research Assistant In Cancer In Primary Care
Melbourne School Of Population And Global Health
Master of Genetic Counselling
University of Melbourne
Bachelor of Science (Genetics)
University of Melbourne